Richard Klausner

Insider Reports History

Location
San Diego, CA
Signature
/s/ Charles Newton, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard Klausner:

Company Role Class Num Shares Value Price $ Report Date Ownership
Lyell Immunopharma, Inc. Director Common Stock 2,967,834 $1,394,881 $0.4700 15 May 2025 Direct
Lyell Immunopharma, Inc. Director Common Stock 843,365 $396,381 $0.4700 15 May 2025 Grantor and Trustee
Lyell Immunopharma, Inc. Director Option (right to buy) 130,000 15 May 2025 Direct
Lyell Immunopharma, Inc. Director Option (right to buy) 130,000 14 Jun 2024 Direct

Insider Reports Filed by Richard Klausner

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LYEL Lyell Immunopharma, Inc. 15 May 2025 1 $0 4 Director 19 May 2025, 18:50
LYEL Lyell Immunopharma, Inc. 14 Mar 2025 1 +$94,942 4 Director 18 Mar 2025, 20:07
LYEL Lyell Immunopharma, Inc. 14 Jun 2024 1 $0 4 Director 17 Jun 2024, 16:15
LYEL Lyell Immunopharma, Inc. 08 Sep 2023 1 $0 4 Director 08 Sep 2023, 16:30
LYEL Lyell Immunopharma, Inc. 15 Aug 2023 1 -$132,286 4 Director 17 Aug 2023, 16:23
LYEL Lyell Immunopharma, Inc. 16 Jun 2023 1 $0 4 Director 20 Jun 2023, 16:45
LYEL Lyell Immunopharma, Inc. 23 Sep 2022 1 -$71,041 4 Director 27 Sep 2022, 18:14
LYEL Lyell Immunopharma, Inc. 21 Jun 2021 2 $0 4 Executive Chairman, Director 23 Jun 2021, 17:36
LYEL Lyell Immunopharma, Inc. 16 Jun 2021 0 $0 3 Executive Chairman, Director 16 Jun 2021, 19:18
LYEL Lyell Immunopharma, Inc. 08 Jun 2021 1 $0 4 Director 10 Jun 2022, 16:08